Current status and future directions in the treatment of peritoneal dissemination from colorectal carcinoma.
about
Outcome following incomplete surgical cytoreduction combined with intraperitoneal chemotherapy for colorectal peritoneal metastasesPeritoneal tumor carcinomatosis: pharmacological targeting with hyaluronan-based bioconjugates overcomes therapeutic indications of current drugsPopulation pharmacokinetics of peritoneal, plasma ultrafiltrated and protein-bound oxaliplatin concentrations in patients with disseminated peritoneal cancer after intraperitoneal hyperthermic chemoperfusion of oxaliplatin following cytoreductive suPeritoneal carcinomatosis of gastrointestinal tumors: where are we now?Bypassing the EPR effect with a nanomedicine harboring a sustained-release function allows better tumor control.Tailoring heated intraperitoneal mitomycin C for peritoneal metastases originating from colorectal carcinoma: a translational approach to improve survival.Systemic treatment of patients with metachronous peritoneal carcinomatosis of colorectal origin.Cytoreductive Surgery plus HIPEC for Peritoneal Metastases from Colorectal CancerDiagnostic Laparoscopy in the Pre-operative Assessment of Patients Undergoing Cytoreductive Surgery and HIPEC for Peritoneal Surface Malignancies.In Search for Optimal Targets for Intraoperative Fluorescence Imaging of Peritoneal Metastasis From Colorectal Cancer.The American Society of Peritoneal Surface Malignancies evaluation of HIPEC with Mitomycin C versus Oxaliplatin in 539 patients with colon cancer undergoing a complete cytoreductive surgery.A Multi-Center Randomized Trial to Evaluate Hematologic Toxicities after Hyperthermic Intraperitoneal Chemotherapy with Oxaliplatin or Mitomycin in Patients with Appendiceal Tumors.Preclinical Evaluation of Cathepsin-Based Fluorescent Imaging System for Cytoreductive Surgery.Correlation of Radiologic with Surgical Peritoneal Cancer Index Scores in Patients with Pseudomyxoma Peritonei and Peritoneal Carcinomatosis: How Well Can We Predict Resectability?Studies on assessment methods of malignant ascites residue and changes of verapamil concentration in intraperitoneal perfusion chemotherapy.Peritoneal carcinomatosis
P2860
Q26774607-CA38CB6D-0786-47F5-8C40-03E76A2A19C3Q28544821-4CB1B844-152F-4052-9E13-ED70601F938DQ33416659-FC6D76FB-E5E4-43E4-9651-24654089E235Q34366940-5BBA4020-8764-42E1-94A5-55200BC56170Q35284185-CA94632F-E8F1-4179-A988-AE3E102A4662Q35678699-B0EABDEA-57AB-4855-BEB3-808D60CBDB40Q36388283-6535A5C6-CF99-416D-92F3-BF18353FF5F8Q36758936-E22B05C8-C158-48CC-A592-72DE6E52CA5AQ38804709-0DB31385-91CD-42C4-AD24-EB5C936E763CQ41560167-4745B9B9-DEBF-4777-A189-6FA7D296CD79Q45823091-391031C4-327C-42B4-962B-018FD9B71AFBQ47553847-757E0298-D9AF-4380-B085-00A8839ED8D4Q52950183-7D6AA335-B0B5-450D-8B8B-303AF36CC277Q53432098-9FA10D06-83AF-4BD4-9BFE-0943200550E9Q53501359-98BCD759-92B4-4260-818E-6BBB4CD36C39Q58766340-DA10D4E9-09EA-4670-8F8B-5506B13EDC7C
P2860
Current status and future directions in the treatment of peritoneal dissemination from colorectal carcinoma.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Current status and future dire ...... ion from colorectal carcinoma.
@en
type
label
Current status and future dire ...... ion from colorectal carcinoma.
@en
prefLabel
Current status and future dire ...... ion from colorectal carcinoma.
@en
P1476
Current status and future dire ...... ion from colorectal carcinoma.
@en
P2093
Dominique Elias
François Quenet
P304
P356
10.1016/J.SOC.2012.07.014
P50
P577
2012-10-01T00:00:00Z